Objectives: Previous studies have reported several different plasmids that confer multidrug resistance (MDR) including resistance to aminoglycosides. In this study, we investigated the aminoglycoside resistance patterns for 224 Escherichia coli isolates from diseased chickens and ducks in China, characterized a novel MDR plasmid, and collected prevalence data on similar resistance plasmids.
Introduction
Aminoglycosides are broad-spectrum antibacterials to which some bacteria have acquired resistance. The primary mechanism of resistance to aminoglycosides is an enzymatic modification of the drug by different classes of enzymes. To date, six plasmid-encoded 16S rRNA methylases, including ArmA, RmtA, RmtB, RmtC, RmtD and NpmA, have been identified in Gramnegative bacilli isolated from different countries. 1 In China, the rmtB gene is the most prevalent 16S rRNA methylase gene among Enterobacteriaceae isolates. 1 -3 Bacterial resistance plasmids constitute an important part of the so-called horizontal gene pool that can be acquired by various bacterial strains by means of horizontal gene transfer. 4 Different plasmids that produce extended-spectrum b-lactamases (ESBLs) 5 and 16S rRNA methylases 6, 7 have been found in Escherichia coli. Data regarding multidrug resistance (MDR) plasmids that can confer resistance to the majority of b-lactams and aminoglycosides are lacking for China. The objective of the present study is to characterize an MDR plasmid from an E. coli isolate, which mediates resistance to b-lactams, fosfomycin and aminoglycosides, and to detect the prevalence of similar resistance plasmids in 224 E. coli isolates by designing a multiplex PCR assay.
Materials and methods

Strains and growth conditions
E. coli ATCC 25922 was originally purchased from ATCC, maintained in our laboratory and used as a control in this study. 
Antibiotic susceptibility testing assay
Several assays for testing antibiotic susceptibility were conducted. According to the criteria recommended by the CLSI, the disc diffusion method was employed to test the antimicrobial susceptibility of the 224 E. coli isolates to different antibiotics, including kanamycin, streptomycin and neomycin. The MICs of amikacin and gentamicin for the E. coli isolates were determined by the microdilution method according to CLSI guidelines.
Identification and sequencing of aminoglycoside resistance plasmid
One of the 224 E. coli strains, isolated from the liver of a sick duck in Jiangsu Province, China in May 2008 and displaying a high degree of resistance to many aminoglycosides, was designated XZDC and chosen for the plasmid isolation. XZDC was cultured in LB medium containing amikacin (1024 mg/L), with shaking at 378C. Plasmid preparation was undertaken using the Plasmid Miniprep Kit (Omega Ltd). The isolated plasmid, designated pXZ, was transferred to E. coli DH5a cells three times consecutively and then was analysed by restriction fragment length polymorphism (RFLP) with EcoRI and SalI. pXZ was sequenced using an ABI PRISM w 3730xl DNA Sequencer. DNA database searches were performed with the Basic Local Alignment Tool (BLASTn) and sequences were compared using DNAStar analysis programs (DNAStar Inc.).
Transfer of antibiotic resistance
A conjugation experiment was carried out to determine whether the antibiotic resistance of pXZ could be transferred. Transconjugants were selected on LB agar plates containing 1024 mg/L amikacin and analysed by RFLP as above when E. coli DH5a was used as the recipient. The antibiotic susceptibilities of DH5a strains with or without pXZ to a panel of antimicrobial drugs (shown in Table 1 ) were determined.
Determination of the occurrence of the MDR-encoding region of pXZ in E. coli clinical isolates
In order to investigate the occurrence of the MDR-encoding region of pXZ in the 224 E. coli isolates, three pairs of primers were designed according to the sequence of pXZ: fosA3-F,
′ -GTGTCGCCCTTATTCCCTT-3 ′ ; and bla TEM-1 -rmtB-R, 5 ′ -TTAT CCATTCTTTTTTATCAAGTATAT-3 ′ . A multiplex PCR method was established and was performed in a final volume of 25 mL containing 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2.5 mM MgCl 2 , 2 mM dNTPs, 1 U of rTaq, 1 nM FosA3-F, FosA3-R, bla CTX-M-24 -F and bla CTX-M-24 -R, 2 nM bla TEM-1 -rmtB-F and bla TEM-1 -rmtB-R, and 1 mL of plasmid DNA (0.05-50 ng). The cycling conditions were: 948C for 5 min, 32 cycles at 948C for 50 s, 508C for 50 s, 728C for 2 min and then 728C for 10 min.
All the isolates positive by the multiplex PCR were cultured in LB medium containing amikacin (1024 mg/L) at 378C. Then, the plasmids were extracted, transferred and analysed by RFLP as for pXZ. The bla CTX-M genes in the plasmids were amplified with the primers bla CTX-M -F (5 ′ -ATGGTGACAAAGAGAGTGCAA-3 ′ ) and bla CTX-M -R (5 ′ -TTACAGCCCTTCG GCGATGATTC-3 ′ ). All the DNA sequences of the PCR products were determined and analysed using the same method and tools as described above.
Results
Among the 224 E. coli isolates, 189 (84.4%) were resistant to streptomycin, 125 (55.8%) were resistant to kanamycin, 116 Sun et al.
(51.8%) were resistant to gentamicin, 106 (47.3%) were resistant to neomycin and 98 (43.8%) were resistant to amikacin. Forty-six isolates displayed a very high level of resistance to gentamicin (MIC ≥512 mg/L), 32 isolates displayed a very high level of resistance to amikacin (MIC ≥512 mg/L), and 26 isolates displayed a very high level of resistance to both gentamicin (MIC ≥512 mg/L) and amikacin (MIC ≥512 mg/L). pXZ was extracted from E. coli XZDC and analysed by restriction enzyme digestion and sequencing. The result of the RFLP showed that pXZ was digested into five fragments by EcoRI and six fragments by SalI (data not shown). pXZ was a circular DNA molecule of 76 635 bp with a 51.65% guanine+ cytosine content, and contained two genetically and physically distinguishable components: a 62 kb region essentially homologous to the non-R-determinant region of plasmid R100 except for several point mutations; and a 15 kb resistance (R-determinant) component (Figure 1 ). Four resistance genes were found in the resistance component: the rmtB gene (pos. 16 341 . . .17 097), encoding the 16S rRNA methylase RmtB that mediates resistance to aminoglycosides (the numbering of pXZ commences at the first nucleotide of the ATG start codon of repA, a gene predicted to encode a replication protein); the fosA3 gene (pos. 10 938. . .11354) encoding the FosA3 enzyme that mediates fosfomycin resistance; and two b-lactamase genes, bla TEM-1 (pos. 15 311. . .16171) and bla CTX-M-24 (pos. 6219 . . .7194), encoding ESBLs that mediate resistance to b-lactams. The annotated sequence of pXZ has been submitted to GenBank and assigned accession number JF927996.
To determine whether the antibiotic resistance of E. coli isolates carrying plasmid pXZ could be transferred to an antibioticsusceptible strain, conjugation experiments were carried out in LB medium using E. coli DH5a as the recipient. The results showed that the MICs of amikacin and gentamicin for the DH5a strain carrying pXZ were .1024 and 512 mg/L, A novel multidrug resistance plasmid 1637 JAC respectively, while for DH5a without pXZ they were only 2 and 0.5 mg/L, respectively. Compared with the DH5a strain without pXZ, the DH5a strain with pXZ significantly was resistant to aminoglycosides, b-lactam antibiotics and fosfomycin, while the DH5a strains with and without pXZ displayed similar susceptibility to the other drugs ( Table 1 ). The results suggested that plasmid pXZ conferred resistance to multiple antibiotics in E. coli. Using the optimized multiplex PCR and RFLP, 17 of the 224 E. coli isolates were found to be positive for plasmid with the MDR-encoding region of pXZ. Among the 17 isolates, 16 were positive for the bla CTX-M-24 gene and 1 for the bla CTX-M-14 gene (GenBank accession numbers JQ003799 -JQ003815). All the 26 rmtB-positive E. coli isolates confirmed by the multiplex PCR showed a very high level of resistance to aminoglycosides (gentamicin and amikacin MICs ≥512 mg/L).
Discussion
In the present study, we sequenced the multiplex resistance plasmid pXZ and detected the prevalence of similar resistance plasmids. Through sequence analysis, it was found that pXZ contained four resistance genes (rmtB, fosA3, bla TEM-1 and bla CTX-M-24 ). In an earlier study, a high prevalence of the plasmid-mediated rmtB gene was found among clinical E. coli isolates (36/680) from a Chinese teaching hospital. 3 In this paper, we found that the rmtB gene has a higher prevalence in avian E. coli isolates (26/224) in China and that RmtB conferred high-level resistance to aminoglycosides in avian E. coli. A recent study showed that bla TEM-1, bla CTX-M-24 and bla CTX-M-15 were co-transferred with rmtB on plasmid to recipients. 3 Similar to previous studies, 3, 6, 8 besides the rmtB gene, the bla TEM-1 and bla CTX-M-24 genes were found to be located on plasmid pXZ. On the quinolone resistance plasmid pKP96, it has been found that the fosfomycin resistance gene fosA co-associated with the bla CTX-M-24 gene. 9 In this study, the fosA3 gene was first found harboured on the aminoglycoside resistance plasmid. Cottell et al.
10 discovered the plasmid pCT that carried a single resistance gene, bla CTX-M-14 , and detected pCT-like plasmids with a series of PCRs that amplified the characteristic region of pCT10. Plasmids with the MDR-encoding region of pXZ were detected in 17 E. coli isolates by multiplex PCR and RFLP, which indicated that this type of plasmid harbouring four resistance genes (rmtB, fosA3, bla TEM-1 and bla CTX-M ) has a high prevalence (17/224) among avian E. coli isolates in China.
